Recombinant BTLA (Tifcemalimab Biosimilar) antibody (Biotin)

Catalog No. ABIN7828960

This Humanized Monoclonal antibody specifically detects BTLA (Tifcemalimab Biosimilar) . It exhibits reactivity toward Human.

Quick Overview for Recombinant BTLA (Tifcemalimab Biosimilar) antibody (Biotin) (ABIN7828960)

Target: BTLA (Tifcemalimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This BTLA (Tifcemalimab Biosimilar) antibody is conjugated to Biotin

Grade: Research Grade

Product Details anti-BTLA (Tifcemalimab Biosimilar) Antibody (Biotin)

Purpose: Biotinylated Anti-BTLA(tifcemalimab biosimilar) mAb

Isotype: IgG4

Application Details

Comment:

Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Reconstitution: Please see Certificate of Analysis for specific instructions of reconstitution.

Buffer: Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.

Storage: -20 °C,-80 °C

Storage Comment: Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.

Expiry Date: 12 months

Target Details for BTLA (Tifcemalimab Biosimilar)

Target: BTLA (Tifcemalimab Biosimilar)

Alternative Name: Tifcemalimab Biosimilar

Target Type: Biosimilar

Background: Synonyms Target:BTLA,BTLA1,CD272
Synonyms Antibody:Icatolimab,JS-004,JS004,JS 004,JS-4,JS4,JS 4,TAB-004,TAB004,TAB 004,TAB-4,TAB4,TAB 4

UniProt: Q7Z6A9